Insider Transactions in Q3 2023 at Crinetics Pharmaceuticals, Inc. (CRNX)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 14
2023
|
Richard Scott Struthers President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+6.87%
|
$10,000
$1.91 P/Share
|
|
Jul 13
2023
|
Richard Scott Struthers President & CEO |
SELL
Open market or private sale
|
Indirect |
14,157
-2.2%
|
$283,140
$20.35 P/Share
|
|
Jul 12
2023
|
Richard Scott Struthers President & CEO |
SELL
Open market or private sale
|
Indirect |
11,459
-1.75%
|
$229,180
$20.17 P/Share
|
|
Jul 11
2023
|
Richard Scott Struthers President & CEO |
SELL
Open market or private sale
|
Indirect |
24,384
-3.58%
|
$487,680
$20.14 P/Share
|